Joseph A Walicki
Insider
First SEC filing: Dec. 11, 2017 · Latest: Dec. 11, 2017
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 7, 2018 | JCI | F | 2,841 | $32.66 | $92,787 | 183,147 Direct | -1.53% | Disposed | 340.8% (price as of ) |
| Dec. 6, 2018 | JCI | A | 19,706 | · | · | 185,988 Direct | +11.85% | Acquired | |
| Dec. 6, 2018 | JCI | A | 118,345 | $33.39 | $3,951,540 | 118,345 Direct | · | Acquired | |
| Oct. 8, 2018 | JCI | F | 31,422 | $36.31 | $1,140,933 | 165,643 Direct | -15.94% | Disposed | 296.5% (price as of ) |
| Dec. 7, 2017 | JCI | A | 17,612 | · | · | 210,961 Direct | +9.11% | Acquired | |
| Dec. 7, 2017 | JCI | F | 17,107 | $37.36 | $639,118 | 193,854 Direct | -8.11% | Disposed | 285.3% (price as of ) |
| Dec. 7, 2017 | JCI | A | 93,333 | · | · | 93,333 Direct | · | Acquired | |
| Nov. 20, 2017 | JCI | F | 2,948 | $36.39 | $107,278 | 193,349 Direct | -1.50% | Disposed | 295.6% (price as of ) |
| Oct. 7, 2017 | JCI | F | 1,824 | $41.07 | $74,912 | 195,261 Direct | -0.93% | Disposed | 250.5% (price as of ) |
| Aug. 31, 2017 | JCI | M | 16,279 | $22.92 | $373,115 | 212,339 Direct | +8.30% | Acquired | 528.1% (price as of ) |
| Aug. 31, 2017 | JCI | D | 16,279 | $39.73 | $646,765 | 196,060 Direct | -7.67% | Disposed | 262.3% (price as of ) |
| Aug. 31, 2017 | JCI | M | 16,279 | · | · | 0 Direct | -100.00% | Disposed | |
| Feb. 6, 2017 | JCI | M | 13,023 | $26.53 | $345,500 | 208,015 Direct | +6.68% | Acquired | 442.6% (price as of ) |
| Feb. 6, 2017 | JCI | D | 13,023 | $42.40 | $552,175 | 194,992 Direct | -6.26% | Disposed | 239.5% (price as of ) |
| Feb. 6, 2017 | JCI | M | 13,023 | · | · | 0 Direct | -100.00% | Disposed | |
| Dec. 13, 2016 | JCI | M | 10,419 | $37.05 | $386,024 | 204,374 Direct | +5.37% | Acquired | 288.6% (price as of ) |
| Dec. 13, 2016 | JCI | D | 10,419 | $43.59 | $454,164 | 193,955 Direct | -5.10% | Disposed | 230.3% (price as of ) |
| Dec. 13, 2016 | JCI | M | 10,419 | · | · | 0 Direct | -100.00% | Disposed | |
| Nov. 21, 2016 | JCI | F | 1,377 | $44.71 | $61,566 | 193,955 Direct | -0.70% | Disposed | 222.0% (price as of ) |
| Nov. 18, 2016 | JCI | A | 34,306 | · | · | 195,332 Direct | +21.30% | Acquired | |
| Oct. 7, 2016 | JCI | A | 14,528 | · | · | 149,655 Direct | +10.75% | Acquired | |
| Oct. 7, 2016 | JCI | A | 73,192 | · | · | 73,192 Direct | · | Acquired | |
| Oct. 7, 2016 | JCI | A | 14,103 | · | · | 149,230 Direct | +10.44% | Acquired | |
| Oct. 7, 2016 | JCI | A | 71,051 | · | · | 71,051 Direct | · | Acquired | |
| Sept. 8, 2016 | JCI | A | 14,478 | · | · | 103,629 Direct | +16.24% | Acquired | |
| Sept. 8, 2016 | JCI | A | 31,341 | · | · | 134,970 Direct | +30.24% | Acquired | |
| Sept. 2, 2016 | JCI | A | 89,308 | · | · | 89,308 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 89,151 | · | · | 89,151 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 3,693 | · | · | 3,693 Indirect | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 9,600 | · | · | 9,600 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 12,000 | · | · | 12,000 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 15,000 | · | · | 15,000 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 13,200 | · | · | 13,200 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 12,500 | · | · | 12,500 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 16,100 | · | · | 16,100 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 11,428 | · | · | 11,428 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 14,478 | · | · | 14,478 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 8,722 | · | · | 8,722 Direct | · | Acquired | |
| Sept. 2, 2016 | JCI | A | 50,038 | · | · | 50,038 Direct | · | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 6, 2018 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $33.39 | Dec. 6, 2028 | 118,345 | Acquired |
| Dec. 7, 2017 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $37.36 | Dec. 7, 2027 | 93,333 | Acquired |
| Aug. 31, 2017 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $22.92 | Oct. 1, 2019 | 16,279 | Disposed |
| Feb. 6, 2017 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $26.53 | Oct. 1, 2018 | 13,023 | Disposed |
| Dec. 13, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $37.05 | Oct. 1, 2017 | 10,419 | Disposed |
| Oct. 7, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $45.29 | Oct. 7, 2026 | 73,192 | Acquired |
| Oct. 7, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $45.29 | Oct. 7, 2026 | 71,051 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $40.21 | Oct. 1, 2017 | 9,600 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $28.79 | Oct. 1, 2018 | 12,000 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $24.87 | Oct. 1, 2019 | 15,000 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $30.54 | Oct. 1, 2020 | 13,200 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $28.54 | Oct. 7, 2021 | 12,500 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $27.85 | Oct. 5, 2022 | 16,100 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $48.37 | Nov. 19, 2023 | 11,428 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $50.23 | Nov. 18, 2024 | 14,478 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $46.31 | Jan. 5, 2025 | 8,722 | Acquired |
| Sept. 2, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares | $43.86 | Oct. 7, 2025 | 50,038 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Holdings reported on Form 4 10 reported holdings
Positions listed on each Form 4 without a transaction in that filing (Table I and II holdings), newest filing first.
| Date | Ticker | Security | Shares | Exercise price | Expiration | Ownership |
|---|---|---|---|---|---|---|
| Dec. 10, 2018 | JCI | Ordinary Shares | 4,474 | · | · | Indirect |
| Dec. 11, 2017 | JCI | Ordinary Shares | 4,336 | · | · | Indirect |
| Nov. 21, 2017 | JCI | Ordinary Shares | 4,336 | · | · | Indirect |
| Oct. 11, 2017 | JCI | Ordinary Shares | 4,300 | · | · | Indirect |
| Sept. 5, 2017 | JCI | Ordinary Shares | 4,302 | · | · | Indirect |
| Feb. 8, 2017 | JCI | Ordinary Shares | 4,248 | · | · | Indirect |
| Dec. 14, 2016 | JCI | Ordinary Shares | 4,222 | · | · | Indirect |
| Nov. 22, 2016 | JCI | Ordinary Shares | 4,221 | · | · | Indirect |
| Oct. 11, 2016 | JCI | Ordinary Shares | 4,235 | · | · | Indirect |
| Sept. 12, 2016 | JCI | Ordinary Shares | 3,693 | · | · | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $421,167 | · | · | · | · | $79,014 | $12,728,476 | $15,860,605 |
| 2018 | $722,000 | · | · | · | $885,518 | · | $190,559 | $4,430,027 |
| 2017 | $722,000 | · | · | · | $875,607 | $23,484 | $238,900 | $4,453,155 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.